Drugs.com - FDA MedWatch Alerts

FDA Warns Health Care Professionals Not to Use Epinephrine Nasal Solutions from BPI Labs and Endo USA

Audience: Health Care Professionals January 16, 2025 -- FDA is warning health care professionals not to use unapproved epinephrine nasal solutions manufactured by BPI Labs LLC, in Largo, Fla., and Endo USA, in Malvern, Pa. Health care professionals...

Feb 9, 2025 - 21:44
 0
FDA Warns Health Care Professionals Not to Use Epinephrine Nasal Solutions from BPI Labs and Endo USA
Audience: Health Care Professionals January 16, 2025 -- FDA is warning health care professionals not to use unapproved epinephrine nasal solutions manufactured by BPI Labs LLC, in Largo, Fla., and Endo USA, in Malvern, Pa. Health care professionals...
Read More

Tags:

Previous Article

Drug Safety Communication: Copaxone, Glatopa (glatiramer acetate) - FDA Adds Box...

Next Article

FDA Requires Guillain-Barré Syndrome (GBS) Warning in the Prescribing Informatio...

Related Posts

Shoppers-Plaza Issues Voluntary Nationwide Recall of Fouzee Sugarlin Herbal Formula Due To Presence Of Undeclared Metformin And Glyburide

Shoppers-Plaza Issues Voluntary Nationwide Recall of Fo...

Feb 9, 2025  0

FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize

FDA Clarifies Policies for Compounders as National GLP-...

Feb 9, 2025  0

FDA Warns Consumers Not to Purchase or Use Umary and Amazy Products As They May Be Harmful To Your Health

FDA Warns Consumers Not to Purchase or Use Umary and Am...

Feb 9, 2025  0